| scholarly article | Q13442814 |
| P2093 | author name string | Lili Zhang | |
| Fang Yang | |||
| Lei Qin | |||
| Ya Zhuo | |||
| Xiaoxia Wei | |||
| Lijuan Hou | |||
| Xinwen Song | |||
| P2860 | cites work | TagFinder for the quantitative analysis of gas chromatography--mass spectrometry (GC-MS)-based metabolite profiling experiments. | Q50657835 |
| 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 | ||
| Sex differences in gut microbiota in patients with major depressive disorder. | Q52665670 | ||
| Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease. | Q52678097 | ||
| Health-Related Quality of Life and Depression in Patients with Chronic Hepatitis C | Q63305767 | ||
| A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats | Q80037913 | ||
| Treatment of chronic hepatitis B | Q82791051 | ||
| Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis | Q26773436 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| The GABAergic deficit hypothesis of major depressive disorder. | Q30464954 | ||
| Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation | Q33231491 | ||
| Analysis of metabolomic data using support vector machines | Q33366103 | ||
| Depression in patients with chronic hepatitis B: an experience on individual solution- focused therapy | Q33596472 | ||
| Novel urinary metabolite signature for diagnosing postpartum depression | Q33704082 | ||
| Metabolomics: a global biochemical approach to drug response and disease | Q34734298 | ||
| MetaboAnalyst 3.0--making metabolomics more meaningful | Q35610559 | ||
| Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients | Q35645024 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis | Q37001709 | ||
| Mitochondria in cancer cells: what is so special about them? | Q37093125 | ||
| Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics | Q37648213 | ||
| Differential urinary metabolites related with the severity of major depressive disorder | Q38669894 | ||
| Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. | Q39017815 | ||
| Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis | Q39563873 | ||
| Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. | Q43187905 | ||
| Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. | Q43695474 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Clinical diagnosis of depression in primary care: a meta-analysis | Q44323103 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. | Q50580085 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| metabolomics | Q12149006 | ||
| hepatitis B | Q6853 | ||
| P304 | page(s) | 2252-2265 | |
| P577 | publication date | 2018-09-02 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age | |
| P478 | volume | 10 |
| Q89628910 | Age-specific differential changes on gut microbiota composition in patients with major depressive disorder |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
| Q90371599 | Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder |
| Q90353598 | Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression |
| Q99583961 | Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma |
| Q64104741 | Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus |
| Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
| Q64262134 | Urinary metabolite signature in bipolar disorder patients during depressive episode |
Search more.